TOP > 外国特許検索 > Substance-encapsulating vesicle and process for producing the same

Substance-encapsulating vesicle and process for producing the same

外国特許コード F130007652
整理番号 AF12-07EP2
掲載日 2013年10月15日
出願国 欧州特許庁(EPO)
出願番号 13166732
公報番号 2626130
公報番号 2626130
出願日 平成23年5月23日(2011.5.23)
公報発行日 平成25年8月14日(2013.8.14)
公報発行日 平成28年7月6日(2016.7.6)
優先権データ
  • 特願2010-117821 (2010.5.21) JP
  • 特願2010-117823 (2010.5.21) JP
  • 11783676 (2011.5.23) EP
発明の名称 (英語) Substance-encapsulating vesicle and process for producing the same
発明の概要(英語) Provided is a method for easily and efficiently producing encapsulated substance vesicles wherein a substance is encapsulated in the cavity of vesicles obtained by polymer self-assembly.
Empty vesicles that have membranes comprising a first polymer that is a block copolymer with uncharged hydrophilic segments and a first kind of charged segments and a second polymer with a second kind of charged segments that carry a charge that is the opposite of said first kind of charged segments as well as spaces that are enclosed by said membranes are mixed in an aqueous medium with the substance that is to be encapsulated in the spaces.
特許請求の範囲(英語) [claim1]
1. A vesicle comprising a membrane containing: a block copolymer having an uncharged hydrophilic segment and a cationic segment; and a nucleic acid; said membrane defining a cavity surrounded thereby, wherein the uncharged hydrophilic segment is polyalkylene glycol and the cationic segment is polyamine, and wherein the molecular weight ratio X of the uncharged hydrophilic segment is within the range of 0.05 < X < 0.1, said weight ratio X being defined as follows: (Equation image 7 not included in text) wherein: M N represents the molecular weight of the uncharged hydrophilic segment, M C represents the molecular weight of the cationic segment, M A represents the molecular weight of the nucleic acid, P C represents the number of cationic amino groups in the cationic segment, P A represents the number of the phosphate groups in the nucleic acid, and N **+/P is the mole ratio of cationic groups of the cationic segment to phosphate groups of the nucleic acid and is within the range of 1.0 < N **+/P < 3.0.
[claim2]
2. The vesicle according to claim 1, wherein the membrane has a trilaminar structure comprising an outer layer, an intermediate layer, and an inner layer.
[claim3]
3. The vesicle according to claim 1 or 2, wherein the membrane further comprises a cross-linker.
[claim4]
4. The vesicle according to claim 3, which has a CL/N ratio of 0.1 or higher, the CL/N ratio being the mole ratio of the cross-linker to cationic groups of the cationic segment.
[claim5]
5. The vesicle according to claim 3 or 4, wherein the cross-linker is glutaraldehyde.
[claim6]
6. The vesicle according to any one of claims 1 to 5 for use in a drug delivery system.
[claim7]
7. The vesicle according to any one of claims 1 to 6, further comprising a drug within the cavity surrounded by the membrane.
  • 出願人(英語)
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
  • 発明者(英語)
  • KATAOKA KAZUNORI
  • KISHIMURA AKIHIRO
  • ANRAKU YASUTAKA
  • MIYATA KANJIRO
  • CHUANOI SAYAN
  • SUMA TOMOYA
  • OBA MAKOTO
国際特許分類(IPC)
指定国 Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
参考情報 (研究プロジェクト等) CREST Establishment of Innovative Manufacturing Technology Based on Nanoscience AREA
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close